Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ammonium Chloride | HCID 25517 | — |
| Reactant | Lithium hydroxide, monohydrate | HCID 168937 | — |
| Reactant | HCID 66975120 | HCID 66975120 | — |
| Solvent | Methanol | HCID 887 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 86663858 | HCID 86663858 | 68% |
Reaction Steps
To a solution of tert-butyl (6R*,7R*)-7-(3,4-dichlorophenyl)-6-{[2-(morpholin-4-yl)-2-oxoethoxy]methyl}-1,4-oxazepane-4-carboxylate (649 mg) in THF (2.5 mL) and methanol (2.5 mL) was added a solution of lithium hydroxide monohydrate (108 mg) in distilled water (1.5 mL), and the mixture was stirred at 70° C. for 2 hr. Furthermore, a solution of lithium hydroxide monohydrate (108 mg) in distilled water (1.5 mL) was added, the mixture was stirred at 70° C. overnight, and neutralized with aqueous ammonium chloride solution, and the mixture was extracted with ethyl acetate. The extract was washed with distilled water and brine, and dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure to give the title compound (381 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08722662B2 |
|---|
| Source dataset | uspto-grants-2014_05 |
|---|
| ORD ID | ord-061c6c90cce242779beca0e13edfd1d3 |
|---|
| Source note | uspto-grants-2014_05 |
|---|